Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Lam J S, Benson M C, O’Donnell M A, Sawczuk A, Gavazzi A, Wechsler M, Sawczuk I S. Bacillus Calmete-Guerin plus interferon-alpha 2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity. Urol Oncol, 2003, 21(5): 354–360
2. Bercovich E, Deriu M, Manferrari F, Irianni G. BCG vs. BCG plus recombinant α-interferon 2b in superficial tumors of the bladder. Arch Ital Urol Androl, 1995, 67(4): 257–260
3. Stricker P, Pryor K, Nicholson T, Goldstein D, Golovsky D, Ferguson R, Nash P, Ehsman S, Rumma J, Mammen G, Penny R. Bacillus Calmette-Gue’rin plus intravesical interferon α-2b in patients with superficial bladder cancer. Urology, 1996, 48(6): 957–961
4. Sarosdy M F, Kierum C A. Combination immunotherapy of murine transitional cell cancer using BCG and an interferon-inducing pyrimidinone. J Urol, 1989, 142(5): 1376–1379
5. Riggs D R, Tarry W F, DeHaven J I, Sosnowski J, Lamm DL. Immunotherapy of murine transitional cell carcinoma of the bladder using α and γ interferon in combination with other forms of immunotherapy. J Urol, 1992, 147(1): 212–214
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献